References
1. Nettersheim F.S., De Vore L., Winkels H. Vaccination in Atherosclerosis. Cells. 2020; 9 (12): 2560. DOI: https://www.doi.org/10.3390/cells9122560
2. Casula M., Colpani O., Xie S., Catapano A.L., Baragetti A. HDL in atherosclerotic cardiovascular disease: in search of a role. Cells. 2021; 10 (8): 1869. DOI: https://www.doi.org/10.3390/cells10081869
3. Matsuura E., Atzeni F., Sarzi-Puttini P., Turiel M., Lopez L.R., Nurmohamed M.T. Is atherosclerosis an autoimmune disease? BMC Med. 2014; 12 (1): 47. DOI: https://www.doi.org/10.1186/1741-7015-12-47
4. Cinoku I.I., Mavragani C.P., Moutsopoulos H.M. Atherosclerosis: beyond the lipid storage hypothesis. The role of autoimmunity. Eur J Clin Invest. 2020; 50 (2): e13195. DOI: https://www.doi.org/10.1111/eci.13195
5. van den Berg V.J., Vroegindewey M.M., Kardys I., Boersma E., Haskard D., Hartley A., Khamis R. Anti-oxidized LDL antibodies and coronary artery disease: a systematic review. Antioxidants (Basel). 2019; 8 (10): 484. DOI: https://www.doi.org/10.3390/antiox8100484
6. Marchini T., Hansen S., Wolf D. ApoB-Specific CD4+ T cells in mouse and human atherosclerosis. Cells. 2021; 10 (2): 446. DOI: https://www.doi.org/10.3390/cells10020446
7. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011; 12 (3): 204–12. DOI: https://www.doi.org/10.1038/ni.2001
8. Gistera A., Hansson G.K. The immunology of atherosclerosis. Nat Rev Nephrol. 2017; 13 (6): 368–80. DOI: https://www.doi.org/10.1038/nrneph.2017.51
9. Kobiyama K., Ley K. Atherosclerosis. Circ Res. 2018; 123 (10): 1118–20. DOI: https://www.doi.org/10.1161/circresaha.118.313816
10. Marchini T., Abogunloko T., Wolf D. Modulating autoimmunity against LDL: development of a vaccine against atherosclerosis. Hamostaseologie. 2021; 41 (6): 447–57. DOI: https://www.doi.org/10.1055/a-1661-1908
11. Nilsson J., Hansson G.K. Vaccination strategies and immune modulation of atherosclerosis. Circ Res. 2020; 126 (9): 1281–96. DOI: https://www.doi.org/10.1161/CIRCRESAHA.120.315942
12. FP7 Health. 2013. Vaccination in Atherosclerosis (VIA). CORDIS. European Commission. URL: https://cordis.europa.eu/project/id/603131 (date of access 10.04.2021).
13. Wolf D., Ley K. Immunity and Inflammation in Atherosclerosis. Circ Res. 2019; 124 (2): 315–27. DOI: https://www.doi.org/10.1161/circresaha.118.313591
14. Pirillo A., Bonacina F., Norata G.D., Catapano A.L. The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis. Curr Atheroscler Rep. 2018; 20 (3): 12. DOI: https://www.doi.org/10.1007/s11883-018-0715-0
15. Menshikov I., Fomina K., Beduleva L. Atherosclerosis in rats after immunization with human native low-density lipoproteins. 15th International Congress of Immunology (ICI) (Milan, August 22–27, 2013). Front Immunol. 2013: 741. DOI: https://www.doi.org/10.3389/conf.fimmu.2013.02.00389
16. Fomina K., Beduleva L., Menshikov I., Anikaeva M., Suntsova D., Sidorov A., Stolyarova E. Immune response to native lipoproteins induces visceral obesity and aortic wall injury in rats: the role of testosterone. Endocr Metab Immune Disord Drug Targets. 2017; 17 (2): 125–33. DOI: https://www.doi.org/10.2174/1871530317666170711154825
17. Fomina K., Beduleva L., Menshikov I., Zerjawi A., Terentiev A., Sidorov A., Khramova T., Abisheva N., Gorbushina A. Аtherosclerosis-like changes in the rabbit aortic wall induced by immunization with native high-density lipoproteins. Immun Inflamm Dis. 2020; 8 (4): 559–67. DOI: https://www.doi.org/10.1002/iid3.339
18. Morgan K., Clague R.B., Shaw M.J., Holt P.J. Native type II collagen-induced arthritis in the rat. I. Incidence and humoral response to collagen. Ann Rheum Dis. 1980; 39 (3): 285–90. DOI: https://www.doi.org/10.1136/ard.39.3.285
19. Trentham D.E., Townes A.S., Kang A.H. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med. 1977; 146 (3): 857–67. DOI: https://www.doi.org/10.1084/jem.146.3.857
20. Fisher M.S., Kurilin V.V., Tereshchenko V.P., Bulygin A.S., Kuznetsova M.S., Ivleva E.K., Sennikov S.V. Experimental model of antigen-collagen-induced arthritis in mice. Immunologiya. 2022; 43 (2): 157–65. DOI: https://doi.org/10.33029/0206-4952-2022-43-2-157-165 (in Russian)
21. Mannie M., Swanborg R.H., Stepaniak J.A. Experimental Autoimmune Encephalomyelitis in the Rat. Curr Protoc Immunol. 2009; 85: 15.2.1–15.2.15. DOI: https://www.doi.org/10.1002/0471142735.im1502s85
22. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226 (1): 497–09. DOI: https://www.doi.org/10.1016/s0021-9258(18)64849-5
23. Bechor S., Nachmias D., Elia N., Haim Y., Vataresca M., Leikin-Frenkel A., Gericke M., Tarnovscki T., Las G., Ridich A. Adipose tissue conditioned media support macrophage lipid-droplet biogenesis by interfering with autophagic flux. Biochim Biophys Acta Mol Cell Biol Lipids. 2017; 1862 (9): 1001–12. DOI: https://www.doi.org/10.1016/j.bbalip.2017.06.012
24. Bobryshev Y.V. Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification. J Pathol. 2005; 205 (5): 641–50. DOI: https://www.doi.org/10.1002/path.1743
25. Salisbury E., Hipp J., Olmsted-Davis E.A., Davis A.R., Heggeness M., Gannon F.H. Histological identification of brown adipose and peripheral nerve involvement in human atherosclerotic vessels. Hum Pathol. 2012; 43 (12): 2213–22. DOI: https://www.doi.org/10.1016/j.humpath.2012.03.013
26. Luo L., Liu M. Adipose tissue in control of metabolism. J Endocrinol. 2016; 231 (3): R77–R99. DOI: https://www.doi.org/10.1530/JOE-16-0211
27. van de Woestijne A.P., Monajemi H., Kalkhoven E., Visseren F.L.J. Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev. 2011; 12 (10): 829–40. DOI: https://www.doi.org/10.1111/j.1467-789X.2011.00900.x
28. Huang J.P., Hsu S.C., Meir Y.J.J., Hsieh P.S., Chang C.C., Chen K.H., Chen J.K., Hung L.M. Role of dysfunctional adipocytes in cholesterol-induced nonobese metabolic syndrome. J Mol Endocrinol. 2018; 60 (4): 307–21. DOI: https://www.doi.org/10.1530/JME-17-0194
29. Boden G. Obesity and Free Fatty Acids (FFA). Endocrinol Metab Clin North Am. 2008; 37 (3): 635–46. DOI: https://www.doi.org/10.1016/j.ecl.2008.06.007
30. Thyberg J., Palmberg L., Nilsson J., Ksiazek T., Sjolund M. Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. Differentiation. 1983; 25 (2): 156–67. DOI: https://www.doi.org/10.1111/j.1432-0436.1984.tb01351.x
31. Holycross B.J., Blank R.S., Thompson M.M., Peach M.J., Owens G.K. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res. 1992; 71 (6): 1525–32. DOI: https://www.doi.org/10.1161/01.res.71.6.1525
32. Han J.H., Park H.S., Lee D.H., Jo J.H., Heo K.S., Myung C.S. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift. Life Sci. 2021; 267: 118978. DOI: https://www.doi.org/10.1016/j.lfs.2020.118978
33. Warner S.J., Libby P. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J Immunol. 1989; 142 (1): 100–9.
34. Lamb F.S., Choi H., Miller M.R., Stark R.J. TNFα and Reactive Oxygen Signaling in Vascular Smooth Muscle Cells in Hypertension and Atherosclerosis. Am J Hypertens. 2020; 33 (10): 902–13. DOI: https://www.doi.org/10.1093/ajh/hpaa089
35. Sima P., Vannucci L., Vetvicka V. Atherosclerosis as autoimmune disease. Ann Trans Med. 2018; 6 (7): 116. DOI: https://www.doi.org/10.21037/atm.2018.02.02
36. Pereira I.A., Borba E.F. The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis. Swiss Med Wkly. 2008; 138 (37–38): 534–9.
37. Nilsson J., Björkbacka H., Fredrikson G.N. Apolipoprotein B100 autoimmunity and atherosclerosis – disease mechanisms and therapeutic potential. Cur Opin Lipidol. 2012; 23 (5): 422–8. DOI: https://www.doi.org/10.1097/mol.0b013e328356ec7c
38. Balmasova I.P., Tsarev V.N., Yushchuk E.N., Dorovskikh A.S., Malova E.S., Karakov K.G., Elbekyan K.S., Arutyunov S.D. Periodontal diseases and atherosclerosis: microecological, metabolic and immunological mechanisms of interconnection. Immunologiya. 2020; 41 (4): 370–80. DOI: https://doi.org/10.33029/0206-4952-2020-41-4-370-380 (in Russian)